Page results
-
Having proton beam therapy: information for children aged 9-12 patient information
-
This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
This page is for cancer patients receiving immunotherapy treatment.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
Information for patients having a surgery via median sternotomy.
-
Patient information for patients having a thymectomy procedure.
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
File results
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0155 - Patient transport policy
-
FOI/2023/0156 - Digital sepsis alerts for obstetric patients
-
FOI/2023/0159 - Local treatment guidelines for Atopic Dermatitis (Atopic Eczema)
-
FOI/2023/0162 - ICT and Procurement strategy and organisational charts
-
FOI/2023/0174 - Integration Engine (IE) within Trust's IT estate
-
FOI/2023/0175 - Treatment for Myelofibrosis